- Home
- MTSI vs QGEN Comparison
MTSI vs QGEN Comparison
Compare MTSI & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTSI
- QGEN
- Stock Information
- Founded
- MTSI 1950
- QGEN 1986
- Country
- MTSI United States
- QGEN Netherlands
- Employees
- MTSI N/A
- QGEN N/A
- Industry
- MTSI Semiconductors
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MTSI Technology
- QGEN Health Care
- Exchange
- MTSI Nasdaq
- QGEN Nasdaq
- Market Cap
- MTSI 9.2B
- QGEN 9.1B
- IPO Year
- MTSI 2012
- QGEN 1996
- Fundamental
- Price
- MTSI $122.17
- QGEN $45.13
- Analyst Decision
- MTSI Strong Buy
- QGEN Buy
- Analyst Count
- MTSI 9
- QGEN 8
- Target Price
- MTSI $130.00
- QGEN $50.53
- AVG Volume (30 Days)
- MTSI 848.2K
- QGEN 1.5M
- Earning Date
- MTSI 05-08-2025
- QGEN 05-07-2025
- Dividend Yield
- MTSI N/A
- QGEN 2.92%
- EPS Growth
- MTSI N/A
- QGEN N/A
- EPS
- MTSI N/A
- QGEN 0.42
- Revenue
- MTSI $845,205,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- MTSI $33.43
- QGEN $6.11
- Revenue Next Year
- MTSI $11.97
- QGEN $6.10
- P/E Ratio
- MTSI N/A
- QGEN $107.32
- Revenue Growth
- MTSI 32.63
- QGEN 3.31
- 52 Week Low
- MTSI $84.00
- QGEN $37.63
- 52 Week High
- MTSI $152.50
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- MTSI 60.13
- QGEN 63.29
- Support Level
- MTSI $120.09
- QGEN $41.77
- Resistance Level
- MTSI $126.18
- QGEN $45.41
- Average True Range (ATR)
- MTSI 2.71
- QGEN 0.65
- MACD
- MTSI -0.56
- QGEN 0.24
- Stochastic Oscillator
- MTSI 45.80
- QGEN 85.93
About MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).